These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 20499219)

  • 1. Melt-in-mouth pellets of fexofenadine hydrochloride using crospovidone as an extrusion-spheronisation aid.
    Jain SP; Mehta DC; Shah SP; Singh PP; Amin PD
    AAPS PharmSciTech; 2010 Jun; 11(2):917-23. PubMed ID: 20499219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of crospovidone as pelletization aid as alternative to microcrystalline cellulose: effects on pellet properties.
    Verheyen P; Steffens KJ; Kleinebudde P
    Drug Dev Ind Pharm; 2009 Nov; 35(11):1325-32. PubMed ID: 19832632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functionality of cross-linked polyvinylpyrrolidone as a spheronization aid: a promising alternative to microcrystalline cellulose.
    Liew CV; Gu L; Soh JL; Heng PW
    Pharm Res; 2005 Aug; 22(8):1387-98. PubMed ID: 16078149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of extrusion aids for successful production of Kollidon
    Loka NC; Saripella KK; Pinto CA; Neau SH
    Drug Dev Ind Pharm; 2018 Apr; 44(4):632-642. PubMed ID: 29183166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disintegrating pellets from a water-insoluble pectin derivative produced by extrusion/spheronisation.
    Tho I; Sande SA; Kleinebudde P
    Eur J Pharm Biopharm; 2003 Nov; 56(3):371-80. PubMed ID: 14602179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Production of pellets via extrusion-spheronisation without the incorporation of microcrystalline cellulose: a critical review.
    Dukić-Ott A; Thommes M; Remon JP; Kleinebudde P; Vervaet C
    Eur J Pharm Biopharm; 2009 Jan; 71(1):38-46. PubMed ID: 18771727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a Novel Co-processed Excipitient Comprising of Xylitol, Mannitol, Microcrystalline Cellulose, and Crospovidone for the Compounding of Memantine Hydrochloride Orally Disintegrating Tablet.
    Hazdi SN; Phang HC; Ng ZQ; Chew YL; Uddin AH; Sarker ZI; Lee SK; Liew KB
    Int J Pharm Compd; 2023; 27(6):522-527. PubMed ID: 38100670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of disintegrants on the properties of multiparticulate tablets comprising starch pellets and excipient granules.
    Mehta S; De Beer T; Remon JP; Vervaet C
    Int J Pharm; 2012 Jan; 422(1-2):310-7. PubMed ID: 22101283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Melt-in-Mouth Multi-particulate System for the Treatment of ADHD: A Convenient Platform for Pediatric Use.
    Patadia J; Tripathi R; Joshi A
    AAPS PharmSciTech; 2016 Aug; 17(4):878-90. PubMed ID: 26392403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of partially hydrolysed polyvinyl alcohol for the production of high drug-loaded sustained release pellets via extrusion-spheronisation and coating: In vitro and in vivo evaluation.
    Verstraete G; De Jaeghere W; Vercruysse J; Grymonpré W; Vanhoorne V; Stauffer F; De Beer T; Bezuijen A; Remon JP; Vervaet C
    Int J Pharm; 2017 Jan; 517(1-2):88-95. PubMed ID: 27919698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of Tablet Formulation of Amorphous Solid Dispersions Prepared by Hot Melt Extrusion Using Quality by Design Approach.
    Agrawal A; Dudhedia M; Deng W; Shepard K; Zhong L; Povilaitis E; Zimny E
    AAPS PharmSciTech; 2016 Feb; 17(1):214-32. PubMed ID: 26757898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physical properties of chitosan pellets produced by extrusion-spheronisation: influence of formulation variables.
    Santos H; Veiga F; Pina M; Podczeck F; Sousa J
    Int J Pharm; 2002 Oct; 246(1-2):153-69. PubMed ID: 12270618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of kappa-carrageenan as alternative pelletisation aid to microcrystalline cellulose in extrusion/spheronisation. II. Influence of drug and filler type.
    Thommes M; Kleinebudde P
    Eur J Pharm Biopharm; 2006 May; 63(1):68-75. PubMed ID: 16325384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Taste masked lipid pellets with enhanced release of hydrophobic active ingredient.
    Vaassen J; Bartscher K; Breitkreutz J
    Int J Pharm; 2012 Jun; 429(1-2):99-103. PubMed ID: 22465412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Production of spherical pellets by a hot-melt extrusion and spheronization process.
    Young CR; Koleng JJ; McGinity JW
    Int J Pharm; 2002 Aug; 242(1-2):87-92. PubMed ID: 12176229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immediate release pellets with lipid binders obtained by solvent-free cold extrusion.
    Krause J; Thommes M; Breitkreutz J
    Eur J Pharm Biopharm; 2009 Jan; 71(1):138-44. PubMed ID: 18805483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of chitosan and sodium alginate and formulation variables on the formation and drug release from pellets prepared by extrusion/spheronisation.
    Chatchawalsaisin J; Podczeck F; Newton JM
    Int J Pharm; 2004 May; 275(1-2):41-60. PubMed ID: 15081137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenylalanine-free taste-masked orodispersible tablets of fexofenadine hydrochloride: development, in vitro evaluation and in vivo estimation of the drug pharmacokinetics in healthy human volunteers.
    Yehia SA; El-Ridi MS; Tadros MI; El-Sherif NG
    Pharm Dev Technol; 2015; 20(5):528-39. PubMed ID: 24490806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of microcrystalline cellulose II (MCCII) as an alternative extrusion-spheronization aid.
    Rojas J; Kumar V
    Pharmazie; 2012 Jul; 67(7):595-7. PubMed ID: 22888514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of kappa-carrageenan as alternative pelletisation aid to microcrystalline cellulose in extrusion/spheronisation. I. Influence of type and fraction of filler.
    Thommes M; Kleinebudde P
    Eur J Pharm Biopharm; 2006 May; 63(1):59-67. PubMed ID: 16326085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.